limber-104: zilurgisertib /- ruxolitinib in patients with mf-associated anemia
Published 11 months ago • 88 plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
1:54
limber-104 update: zilurgisertib as monotherapy or with ruxolitinib in patients with mf and anemia
-
2:21
an update from limber-104: zilurgisertib /- ruxolitinib in the management of mf-associated anemia
-
2:30
zilurgisertib as monotherapy or in combination with ruxolitinib in patients with mf-related anemia
-
1:47
limber-treg108: ck0804 add-on therapy in patients with mf with suboptimal response to ruxolitinib
-
6:44
how does jakafi® (ruxolitinib) work?
-
9:22
haemolytic anaemia blood film made easy!
-
3:30
unmet needs in mf: managing anemia & improving the efficacy of first and second-line treatments
-
2:10
phase i study of ruxolitinib in combination with abemaciclib in patients with myelofibrosis
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
0:46
xport-mf-034: selinexor plus ruxolitinib in jak-inhibitor naïve myelofibrosis
-
1:38
pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
-
1:16
the rationale for combining magrolimab with ruxolitinib in myelofibrosis
-
2:54
ruxolitinib in the real world: myelofibrosis
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
1:28
momelotinib in 2024: how should this agent be used in mf with anemia?
-
2:10
management of ruxolitinib failure in myelofibrosis
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:04
updated long-term follow-up of sequoia: zanubrutinib vs bendamustine-rituximab in untreated cll/sll
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:06
fedratinib: mpn-associated myelofibrosis